Literature DB >> 12174121

Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders.

L Beretta, M Caronni, M Vanoli, R Scorza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12174121     DOI： 10.1046/j.1365-2133.2002.48901.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  13 in total

1.  Systemic sclerosis and lupus: points in an interferon-mediated continuum.

Authors:  Shervin Assassi; Maureen D Mayes; Frank C Arnett; Pravitt Gourh; Sandeep K Agarwal; Terry A McNearney; Damien Chaussabel; Nancy Oommen; Michael Fischbach; Kairav R Shah; Julio Charles; Virginia Pascual; John D Reveille; Filemon K Tan
Journal:  Arthritis Rheum       Date:  2010-02

Review 2.  Environmental risk factors of systemic sclerosis.

Authors:  Isabelle Marie; Jean-François Gehanno
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

3.  Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis.

Authors:  Xiaochun Liu; Maureen D Mayes; Filemon K Tan; Minghua Wu; John D Reveille; Brock E Harper; Hilda T Draeger; Emilio B Gonzalez; Shervin Assassi
Journal:  Arthritis Rheum       Date:  2013-01

Review 4.  Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature.

Authors:  Soner Senel; Emin Kaya; Ismet Aydogdu; M Ali Erkurt; Irfan Kuku
Journal:  Rheumatol Int       Date:  2006-01-11       Impact factor: 2.631

Review 5.  Type I Interferons in Autoimmunity.

Authors:  Ruth Fernandez-Ruiz; Timothy B Niewold
Journal:  J Invest Dermatol       Date:  2022-01-10       Impact factor: 8.551

6.  Treatment of chronic hepatitis C in a patient affected by systemic sclerosis.

Authors:  Guido Poggi; Laura Villani; Federico Sottotetti; Barbara Tagliaferri; Benedetta Montagna; Alessio Amatu; Giovanni Bernardo
Journal:  Gastroenterol Res Pract       Date:  2009-11-17       Impact factor: 2.260

7.  The development of systemic sclerosis in a female patient with multiple sclerosis following beta interferon treatment.

Authors:  A Powell; M L Myles; E Yacyshyn
Journal:  Clin Rheumatol       Date:  2008-08-15       Impact factor: 2.980

8.  Onset and enhancement of systemic sclerosis after treatments for multiple sclerosis.

Authors:  Paolo Airo'; Mirko Scarsi; Mara Rossi; Michele Mondini
Journal:  Rheumatol Int       Date:  2007-12-08       Impact factor: 2.631

Review 9.  Toll-like receptors in mediating pathogenesis in systemic sclerosis.

Authors:  L Frasca; R Lande
Journal:  Clin Exp Immunol       Date:  2020-02-21       Impact factor: 4.330

10.  Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?

Authors:  Jo N Fleming; Richard A Nash; D O McLeod; David F Fiorentino; Howard M Shulman; M Kari Connolly; Jerry A Molitor; Gretchen Henstorf; Robert Lafyatis; David K Pritchard; Lawrence D Adams; Daniel E Furst; Stephen M Schwartz
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.